Results 91 to 100 of about 7,879,142 (348)

Simultaneous inhibition of TRIM24 and TRIM28 sensitises prostate cancer cells to antiandrogen therapy, decreasing VEGF signalling and angiogenesis

open access: yesMolecular Oncology, EarlyView.
TRIM24 and TRIM28 are androgen receptor (AR) coregulators which exhibit increased expression with cancer progression. Both TRIM24 and TRIM28 combine to influence the response of castrate‐resistant prostate cancer (CRPC) cells to AR inhibitors by mediating AR signalling, regulation of MYC and upregulating VEGF to promote angiogenesis. Castrate‐resistant
Damien A. Leach   +8 more
wiley   +1 more source

Beyond cytotoxic T cells: reprogrammed regulatory T cells help facilitate response to dual checkpoint blockade

open access: yesMolecular Oncology, EarlyView.
Rolig, Peng, and colleagues have shed new light on how dual blockade of PD1 and LAG3 enhances antitumor immunity. They found that response to immunotherapy with anti‐PD1 + anti‐LAG3 was associated with reprogramming of canonically suppressive CD4+ regulatory T cells to an inflammatory state.
Tullia C. Bruno, Anthony R. Cillo
wiley   +1 more source

Mongolian medicine: History, development and existing problems. [PDF]

open access: yesChin Herb Med, 2022
Qu S, Bao J, Ao W, Bai L, Borjigidai A.
europepmc   +1 more source

Vladan Đorđević, the life and work of a gymnast, scientist, politician, writer and the progenitor of gymnastics and the Sokol Movement in Serbia [PDF]

open access: yesFizička Kultura, 2018
Vladan Đorđević belonged to a generation of Belgrade Lyceum students, who later became influential representatives of science, society and politics. Tireless engagement in the social life of Belgrade and the Kingdom of Serbia, diligent performance of ...
Vukašinović Vladan
doaj  

Small modifier, big decision: switching to SUMO mode adds weight to cancer stemness in mammary tumors

open access: yesMolecular Oncology, EarlyView.
Inhibition of protein SUMOylation has been shown to block tumorigenesis; however, the specific mechanisms by which SUMOylation controls the tumor‐initiating capacities remain elusive. Li et al. describe the role of Etv1 SUMOylation in cancer stem cells using mouse models of mammary gland tumorigenesis.
Veronika Yevdokimova, Yannick D. Benoit
wiley   +1 more source

[The use of radioactive substances in medicine - history and development prospects]. [PDF]

open access: yesProbl Endokrinol (Mosk), 2021
Sheremeta MS, Trukhin AA, Korchagina MO.
europepmc   +1 more source

An Investigation of the Transfer of Traditional Medicines from the Northern Routes of the Persian Gulf to Shiraz in the Al-Buwayh Period [PDF]

open access: yesJournal of Research on History of Medicine, 2020
The transfer of medicine through the Northern roads of the Persian Gulf to the shores and backshores of the Persian Gulf has a long history. In the history of post-Islamic Iran, al-Buwayh was the first government who facilitated the transfer of medicine ...
Fathali Bozorgmehrnejad   +2 more
doaj  

The critical role of DNA damage‐inducible transcript 4 (DDIT4) in stemness character of leukemia cells and leukemia initiation

open access: yesMolecular Oncology, EarlyView.
Stemness properties, including quiescence, self‐renewal, and chemoresistance, are closely associated with leukemia relapse. Here, we demonstrate that DNA damage‐inducible transcript 4 (DDIT4) is induced in the hypoxic bone marrow niche and is essential for maintaining the stemness of AML1‐ETO9a leukemia cells.
Yishuang Li   +12 more
wiley   +1 more source

Identifying prognostic targets in metastatic prostate cancer beyond AR

open access: yesFEBS Open Bio, EarlyView.
Genome‐wide functional screens combined with a large gene expression database and clinical outcomes can identify new therapeutic vulnerabilities in prostate cancer. Eight potentially druggable targets demonstrated strong dependency in cell lines, were associated with worse prognosis clinically, and showed evidence of protein expression in prostate ...
Emily Feng   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy